Literature DB >> 24910257

CD3G gene defects in familial autoimmune thyroiditis.

B Gokturk1, S Keles, M Kirac, H Artac, H Tokgoz, S N Guner, U Caliskan, Z Caliskaner, M van der Burg, J van Dongen, N V Morgan, I Reisli.   

Abstract

The patients with CD3γ deficiency can present with different clinical findings despite having the same homozygous mutation. We report three new CD3gamma-deficient siblings from a consanguineous family with a combined T-B+NK+ immunodeficiency and their variable clinical and cellular phenotypes despite the same homozygous mutation of the CD3G gene (c.80-1G>C). We also re-evaluate a previously reported non-consanguineous family with two CD3gamma-deficient siblings with the same mutation. The median age at diagnosis was 11 years (14 months-20 years). We found all five patients to display autoimmunity: autoimmune thyroiditis (n = 5), autoimmune haemolytic anaemia (n = 2), immune thrombocytopenia (n = 1), autoimmune hepatitis (n = 1), minimal change nephrotic syndrome (n = 1), vitiligo (n = 1) and positive antinuclear antibodies (n = 3) as well as high IgE (n = 2) and atopic eczema (n = 2). While CD3(+) TCRαβ+T cell percentages were low in all patients, only one had lymphopenia and 3 had CD3(+) T cell lymphopenia. Strikingly, we report frequent and multiple autoimmunity in tested heterozygous carriers in both families (n = 6; in 67%), and frequent autoimmunity in family members not available for testing (n = 5, in 80%). The results suggest that CD3G should be studied as a candidate gene for autoimmunity and that CD3gamma deficiency should be considered among other primary immunodeficiencies with predominantly autoimmune manifestations.
© 2014 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24910257     DOI: 10.1111/sji.12200

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  6 in total

1.  Patients with CD3G mutations reveal a role for human CD3γ in Treg diversity and suppressive function.

Authors:  Jared H Rowe; Ottavia M Delmonte; Sevgi Keles; Brian D Stadinski; Adam K Dobbs; Lauren A Henderson; Yasuhiro Yamazaki; Luis M Allende; Francisco A Bonilla; Luis I Gonzalez-Granado; Seyma Celikbilek Celik; Sukru N Guner; Hasan Kapakli; Christina Yee; Sung-Yun Pai; Eric S Huseby; Ismail Reisli; Jose R Regueiro; Luigi D Notarangelo
Journal:  Blood       Date:  2018-04-13       Impact factor: 22.113

2.  MIMIC: an optimization method to identify cell type-specific marker panel for cell sorting.

Authors:  Meng Zou; Zhana Duren; Qiuyue Yuan; Henry Li; Andrew Paul Hutchins; Wing Hung Wong; Yong Wang
Journal:  Brief Bioinform       Date:  2021-11-05       Impact factor: 11.622

Review 3.  Primary immunodeficiencies associated with eosinophilia.

Authors:  Behdad Navabi; Julia Elizabeth Mainwaring Upton
Journal:  Allergy Asthma Clin Immunol       Date:  2016-05-24       Impact factor: 3.406

Review 4.  Is Graves' disease a primary immunodeficiency? New immunological perspectives on an endocrine disease.

Authors:  Tristan Struja; Alexander Kutz; Stefan Fischli; Christian Meier; Beat Mueller; Mike Recher; Philipp Schuetz
Journal:  BMC Med       Date:  2017-09-25       Impact factor: 8.775

5.  A Novel CD3G Mutation in a Taiwanese Patient With Normal T Regulatory Function Presenting With the CVID Phenotype Free of Autoimmunity-Analysis of all Genotypes and Phenotypes.

Authors:  Wen-I Lee; Wen-Lang Fan; Chun-Hao Lu; Shih-Hsiang Chen; Ming-Ling Kuo; Syh-Jae Lin; Weng-Sheng Tsai; Tang-Her Jaing; Li-Chen Chen; Kuo-Wei Yeh; Tsung-Chieh Yao; Jing-Long Huang
Journal:  Front Immunol       Date:  2019-12-19       Impact factor: 7.561

6.  The role of the different CD3γ domains in TCR expression and signaling.

Authors:  Beatriz Garcillán; Rebeca F Megino; Marta Herrero-Alonso; Alberto C Guardo; Veronica Perez-Flores; Claudia Juraske; Vincent Idstein; Jose M Martin-Fernandez; Carsten Geisler; Wolfgang W A Schamel; Ana V Marin; Jose R Regueiro
Journal:  Front Immunol       Date:  2022-09-02       Impact factor: 8.786

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.